-
2
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61(2):69-90.
-
(2011)
CA: a cancer journal for clinicians
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
3
-
-
84860266865
-
International variation in prostate cancer incidence and mortality rates
-
Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O and Bray F. International variation in prostate cancer incidence and mortality rates. European urology. 2012; 61(6):1079-1092.
-
(2012)
European urology
, vol.61
, Issue.6
, pp. 1079-1092
-
-
Center, M.M.1
Jemal, A.2
Lortet-Tieulent, J.3
Ward, E.4
Ferlay, J.5
Brawley, O.6
Bray, F.7
-
4
-
-
0025849053
-
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
-
Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA and Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. The New England journal of medicine. 1991; 324(17):1156-1161.
-
(1991)
The New England journal of medicine
, vol.324
, Issue.17
, pp. 1156-1161
-
-
Catalona, W.J.1
Smith, D.S.2
Ratliff, T.L.3
Dodds, K.M.4
Coplen, D.E.5
Yuan, J.J.6
Petros, J.A.7
Andriole, G.L.8
-
5
-
-
4544254807
-
The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
-
Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M and Downs J. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol. 2004; 172(4 Pt 1):1297-1301.
-
(2004)
J Urol
, vol.172
, Issue.4
, pp. 1297-1301
-
-
Stamey, T.A.1
Caldwell, M.2
McNeal, J.E.3
Nolley, R.4
Hemenez, M.5
Downs, J.6
-
6
-
-
57849142844
-
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)
-
Loeb S, Gashti SN and Catalona WJ. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urologic oncology. 2009; 27(1):64-66.
-
(2009)
Urologic oncology
, vol.27
, Issue.1
, pp. 64-66
-
-
Loeb, S.1
Gashti, S.N.2
Catalona, W.J.3
-
7
-
-
84884526271
-
Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis
-
Chen R, Ren S, Meng T, Aguilar J and Sun Y. Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis. PloS one. 2013; 8(9):e74775.
-
(2013)
PloS one
, vol.8
, Issue.9
-
-
Chen, R.1
Ren, S.2
Meng, T.3
Aguilar, J.4
Sun, Y.5
-
8
-
-
50349102353
-
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
-
Saramaki OR, Harjula AE, Martikainen PM, Vessella RL, Tammela TL and Visakorpi T. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. Clinical cancer research: an official journal of the American Association for Cancer Research. 2008; 14(11):3395-3400.
-
(2008)
Clinical cancer research: an official journal of the American Association for Cancer Research
, vol.14
, Issue.11
, pp. 3395-3400
-
-
Saramaki, O.R.1
Harjula, A.E.2
Martikainen, P.M.3
Vessella, R.L.4
Tammela, T.L.5
Visakorpi, T.6
-
9
-
-
4143083823
-
A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions
-
Zielie PJ, Mobley JA, Ebb RG, Jiang Z, Blute RD and Ho SM. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions. The Journal of urology. 2004; 172(3):1130-1133.
-
(2004)
The Journal of urology
, vol.172
, Issue.3
, pp. 1130-1133
-
-
Zielie, P.J.1
Mobley, J.A.2
Ebb, R.G.3
Jiang, Z.4
Blute, R.D.5
Ho, S.M.6
-
10
-
-
60149091657
-
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
-
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009; 457(7231):910-914.
-
(2009)
Nature
, vol.457
, Issue.7231
, pp. 910-914
-
-
Sreekumar, A.1
Poisson, L.M.2
Rajendiran, T.M.3
Khan, A.P.4
Cao, Q.5
Yu, J.6
Laxman, B.7
Mehra, R.8
Lonigro, R.J.9
Li, Y.10
Nyati, M.K.11
Ahsan, A.12
Kalyana-Sundaram, S.13
Han, B.14
Cao, X.15
Byun, J.16
-
11
-
-
67649444693
-
Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice
-
Marks LS and Bostwick DG. Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice. Reviews in urology. 2008; 10(3):175-181.
-
(2008)
Reviews in urology
, vol.10
, Issue.3
, pp. 175-181
-
-
Marks, L.S.1
Bostwick, D.G.2
-
12
-
-
0033429470
-
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer
-
Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs WB. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer research. 1999; 59(23):5975-5979.
-
(1999)
Cancer research
, vol.59
, Issue.23
, pp. 5975-5979
-
-
Bussemakers, M.J.1
van Bokhoven, A.2
Verhaegh, G.W.3
Smit, F.P.4
Karthaus, H.F.5
Schalken, J.A.6
Debruyne, F.M.7
Ru, N.8
Isaacs, W.B.9
-
14
-
-
0344429906
-
Malat-1 a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer
-
Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H and Muller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22(39):8031-8041.
-
(2003)
Oncogene
, vol.22
, Issue.39
, pp. 8031-8041
-
-
Ji, P.1
Diederichs, S.2
Wang, W.3
Boing, S.4
Metzger, R.5
Schneider, P.M.6
Tidow, N.7
Brandt, B.8
Buerger, H.9
Bulk, E.10
Thomas, M.11
Berdel, W.E.12
Serve, H.13
Muller-Tidow, C.14
-
15
-
-
84860350928
-
Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
-
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM and Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2011.
-
(2011)
Med Oncol
-
-
Lai, M.C.1
Yang, Z.2
Zhou, L.3
Zhu, Q.Q.4
Xie, H.Y.5
Zhang, F.6
Wu, L.M.7
Chen, L.M.8
Zheng, S.S.9
-
16
-
-
78249258719
-
MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes
-
Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K and Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010; 584(22):4575-4580.
-
(2010)
FEBS Lett
, vol.584
, Issue.22
, pp. 4575-4580
-
-
Tano, K.1
Mizuno, R.2
Okada, T.3
Rakwal, R.4
Shibato, J.5
Masuo, Y.6
Ijiri, K.7
Akimitsu, N.8
-
17
-
-
33644926132
-
Phenotypic characterization of endometrial stromal sarcoma of the uterus
-
Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, Ishiyama T and Noguchi M. Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci. 2006; 97(2):106-112.
-
(2006)
Cancer Sci
, vol.97
, Issue.2
, pp. 106-112
-
-
Yamada, K.1
Kano, J.2
Tsunoda, H.3
Yoshikawa, H.4
Okubo, C.5
Ishiyama, T.6
Noguchi, M.7
-
18
-
-
79955996135
-
MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis
-
Xu C, Yang M, Tian J, Wang X and Li Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol. 2011; 39(1):169-175.
-
(2011)
Int J Oncol
, vol.39
, Issue.1
, pp. 169-175
-
-
Xu, C.1
Yang, M.2
Tian, J.3
Wang, X.4
Li, Z.5
-
19
-
-
84862777104
-
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancerassociated long noncoding RNAs and aberrant alternative splicings
-
Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, Cui Z, Zhang J, Yi K, Xu W, Chen C, Wang F, Guo X, Lu J, Yang J, Wei M, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancerassociated long noncoding RNAs and aberrant alternative splicings. Cell Res. 2012; 22(5):806-821.
-
(2012)
Cell Res
, vol.22
, Issue.5
, pp. 806-821
-
-
Ren, S.1
Peng, Z.2
Mao, J.H.3
Yu, Y.4
Yin, C.5
Gao, X.6
Cui, Z.7
Zhang, J.8
Yi, K.9
Xu, W.10
Chen, C.11
Wang, F.12
Guo, X.13
Lu, J.14
Yang, J.15
Wei, M.16
-
20
-
-
38849169937
-
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
-
Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA and Chinnaiyan AM. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer research. 2008; 68(3):645-649.
-
(2008)
Cancer research
, vol.68
, Issue.3
, pp. 645-649
-
-
Laxman, B.1
Morris, D.S.2
Yu, J.3
Siddiqui, J.4
Cao, J.5
Mehra, R.6
Lonigro, R.J.7
Tsodikov, A.8
Wei, J.T.9
Tomlins, S.A.10
Chinnaiyan, A.M.11
-
21
-
-
0034066944
-
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1 051 men
-
discussion 1148-1149
-
Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC and Marberger M. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. The Journal of urology. 2000; 163(4):1144-1148; discussion 1148-1149.
-
(2000)
The Journal of urology
, vol.163
, Issue.4
, pp. 1144-1148
-
-
Djavan, B.1
Zlotta, A.2
Remzi, M.3
Ghawidel, K.4
Basharkhah, A.5
Schulman, C.C.6
Marberger, M.7
-
22
-
-
63249122661
-
Mortality results from a randomized prostate-cancer screening trial
-
Andriole GL, Crawford ED, Grubb RL, 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, et al. Mortality results from a randomized prostate-cancer screening trial. The New England journal of medicine. 2009; 360(13):1310-1319.
-
(2009)
The New England journal of medicine
, vol.360
, Issue.13
, pp. 1310-1319
-
-
Andriole, G.L.1
Crawford, E.D.2
Grubb I.I.I, R.L.3
Buys, S.S.4
Chia, D.5
Church, T.R.6
Fouad, M.N.7
Gelmann, E.P.8
Kvale, P.A.9
Reding, D.J.10
Weissfeld, J.L.11
Yokochi, L.A.12
O'Brien, B.13
Clapp, J.D.14
Rathmell, J.M.15
Riley, T.L.16
-
23
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized European study
-
Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Maattanen L, Bangma CH, Aus G, et al. Screening and prostate-cancer mortality in a randomized European study. The New England journal of medicine. 2009; 360(13):1320-1328.
-
(2009)
The New England journal of medicine
, vol.360
, Issue.13
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
Tammela, T.L.4
Ciatto, S.5
Nelen, V.6
Kwiatkowski, M.7
Lujan, M.8
Lilja, H.9
Zappa, M.10
Denis, L.J.11
Recker, F.12
Berenguer, A.13
Maattanen, L.14
Bangma, C.H.15
Aus, G.16
-
25
-
-
84355162829
-
Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration
-
Shao Q, Ouyang J, Fan Y, Xie J, Zhou J, Wu J, Karim Kader A, Xu J, Liu G, Shan Y, Wen D and Zhang Y. Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration. Cancer letters. 2012; 315(2):170-177.
-
(2012)
Cancer letters
, vol.315
, Issue.2
, pp. 170-177
-
-
Shao, Q.1
Ouyang, J.2
Fan, Y.3
Xie, J.4
Zhou, J.5
Wu, J.6
Karim Kader, A.7
Xu, J.8
Liu, G.9
Shan, Y.10
Wen, D.11
Zhang, Y.12
-
26
-
-
84997532459
-
Cancer incidence in Shanghai Urban area 2009
-
(in Chinese)
-
Control SCoD. Cancer incidence in Shanghai Urban area, 2009. TumorSci (in Chinese). 2012; 32(10):854.
-
(2012)
TumorSci
, vol.32
, Issue.10
, pp. 854
-
-
-
27
-
-
84879353600
-
Age-specific prostate specific antigen cutoffs for guiding biopsy decision in chinese population
-
Na R, Wu Y, Xu J, Jiang H and Ding Q. Age-specific prostate specific antigen cutoffs for guiding biopsy decision in chinese population. PloS one. 2013; 8(6):e67585.
-
(2013)
PloS one
, vol.8
, Issue.6
-
-
Na, R.1
Wu, Y.2
Xu, J.3
Jiang, H.4
Ding, Q.5
-
28
-
-
0028800933
-
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
-
Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL and Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA: the journal of the American Medical Association. 1995; 274(15):1214-1220.
-
(1995)
JAMA: the journal of the American Medical Association
, vol.274
, Issue.15
, pp. 1214-1220
-
-
Catalona, W.J.1
Smith, D.S.2
Wolfert, R.L.3
Wang, T.J.4
Rittenhouse, H.G.5
Ratliff, T.L.6
Nadler, R.B.7
-
29
-
-
84871928105
-
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay
-
Hansen J, Auprich M, Ahyai SA, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Fisch M, Abbou CC, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, et al. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay. European urology. 2013; 63(2):201-209.
-
(2013)
European urology
, vol.63
, Issue.2
, pp. 201-209
-
-
Hansen, J.1
Auprich, M.2
Ahyai, S.A.3
de la Taille, A.4
van Poppel, H.5
Marberger, M.6
Stenzl, A.7
Mulders, P.F.8
Huland, H.9
Fisch, M.10
Abbou, C.C.11
Schalken, J.A.12
Fradet, Y.13
Marks, L.S.14
Ellis, W.15
Partin, A.W.16
-
30
-
-
79961222799
-
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
-
Tomlins SA, Aubin SM, Siddiqui J, Lonigro RJ, Sefton-Miller L, Miick S, Williamsen S, Hodge P, Meinke J, Blase A, Penabella Y, Day JR, Varambally R, Han B, Wood D, Wang L, et al. Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Science translational medicine. 2011; 3(94):94ra72.
-
(2011)
Science translational medicine
, vol.3
, Issue.94
-
-
Tomlins, S.A.1
Aubin, S.M.2
Siddiqui, J.3
Lonigro, R.J.4
Sefton-Miller, L.5
Miick, S.6
Williamsen, S.7
Hodge, P.8
Meinke, J.9
Blase, A.10
Penabella, Y.11
Day, J.R.12
Varambally, R.13
Han, B.14
Wood, D.15
Wang, L.16
-
31
-
-
84997493803
-
Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3 073 Men Undergoing Initial Prostate Biopsy
-
Chevli KK, Duff M, Walter P, Yu C, Capuder B, Elshafei A, Malczewski S, Kattan MW and Jones JS. Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy. The Journal of urology. 2013.
-
(2013)
The Journal of urology
-
-
Chevli, K.K.1
Duff, M.2
Walter, P.3
Yu, C.4
Capuder, B.5
Elshafei, A.6
Malczewski, S.7
Kattan, M.W.8
Jones, J.S.9
-
32
-
-
80053315206
-
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer
-
Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B and van der Poel H. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. European urology. 2011; 60(5):1045-1054
-
(2011)
European urology
, vol.60
, Issue.5
, pp. 1045-1054
-
-
Auprich, M.1
Bjartell, A.2
Chun, F.K.3
de la Taille, A.4
Freedland, S.J.5
Haese, A.6
Schalken, J.7
Stenzl, A.8
Tombal, B.9
van der Poel, H.10
|